Apasomics
Founded 2024 · 4 employees on LinkedIn · 2 known investors
Find your way into Apasomics
Sign up to see every warm intro you have to Apasomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Apasomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
APASOMICS develops Apasomes, a drug delivery system using hydroxyapatite nanospheres designed to deliver bone-targeting medications like bisphosphonates more effectively while reducing side effects, for patients with osteoporosis and other bone diseases.
Founders & leadership
Apasomics was founded in 2024 by Mavis Montero Villalobos.
MM

Mavis Montero VillalobosCEO & Co-Founder
Investors · 2
Frequently asked questions
- What does Apasomics do?
- APASOMICS develops Apasomes, a drug delivery system using hydroxyapatite nanospheres designed to deliver bone-targeting medications like bisphosphonates more effectively while reducing side effects, for patients with osteoporosis and other bone diseases.
- Who founded Apasomics?
- Apasomics was founded by Mavis Montero Villalobos in 2024.
- Who are Apasomics's investors?
- Apasomics's investors include GRIDX, The Innovation Space.


